NDC 72426-818 – Nexlizet
Bempedoic Acid 180 mg/1; Ezetimibe 10 mg/1 · Tablet, Film Coated · Oral
Product NDC72426-818
Product details
- Brand name
- Nexlizet
- Generic name
- Bempedoic Acid and Ezetimibe
- Labeler
- Esperion Therapeutics, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA211617
- Marketed since
- March 9, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Adenosine Triphosphate-Citrate Lyase Inhibitor; Dietary Cholesterol Absorption Inhibitor
Active ingredients
- Bempedoic Acid 180 mg/1
- Ezetimibe 10 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72426-818-03 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03) | Mar 9, 2020 |
| 72426-818-99 sample | 7 TABLET, FILM COATED in 1 BLISTER PACK (72426-818-99) | Mar 9, 2020 |
Recalls mentioning this NDC
- D-0441-2024 Apr 24, 2024 · Class III
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint. - D-1143-2023 Sep 13, 2023 · Class III
Failed dissolution specifications: below specification results at stability 12-month